Variable | Model 1 | Model 2 | ||
---|---|---|---|---|
Unable to talk vs. Able to talk | Did not want to talk vs. Able to talk | |||
OR (95% CI) | AOR (95% CI) | OR (95% CI) | AOR (95% CI) | |
Age (per year increase) | 0.96 (0.94, 0.98) | 0.94 (0.91, 0.97) | 0.99 (0.97, 1.01) | – |
Male (vs. female and non-binary) | 1.05 (0.63, 1.74) | – | 1.74 (1.07, 2.83) | – |
White (vs. IBPOC) | 2.26 (1.29, 3.94) | 3.35 (1.72, 6.51) | 0.82 (0.51, 1.32) | – |
 ≥ Secondary school | 0.90 (0.55, 1.47) | – | 0.80 (0.50, 1.29) | – |
Chronic paina,b | 1.77 (1.08, 2.89) | 1.82 (1.02, 3.27) | 1.77 (1.08, 2.89) | – |
Moderate/severe depression or anxietyc | 5.19 (2.76, 9.76) | 4.66 (2.27, 9.57) | 5.19 (2.76, 9.76) | – |
DTES residencea | 0.79 (0.48, 1.29) | – | 0.79 (0.48, 1.29) | – |
Homelessa | 1.50 (0.74, 3.04) | – | 1.50 (0.74, 3.04) | – |
Incarcerationa | 1.28 (0.24, 6.71) | – | 1.28 (0.24, 6.71) | – |
Negative police encountera,d | 2.04 (0.65, 6.42) | – | 2.04 (0.65, 6.42) | – |
Non-fatal overdosea | 2.42 (1.29, 4.52) | – | 2.42 (1.29, 4.52) | – |
Self-reported substance usea | ||||
 Daily unregulated opioids usee | 1.46 (0.90, 2.39) | – | 1.46 (0.90, 2.39) | – |
 Daily PO use | 3.23 (0.79, 13.22) | – | 3.23 (0.79, 13.22) | – |
 Daily stimulants usef | 1.61 (0.97, 2.66) | – | 1.61 (0.97, 2.66) | – |
 Injection drug useg | 1.33 (0.80, 2.20) | – | 1.33 (0.80, 2.20) | – |
Experiences since beginning COVID-19 | ||||
 Increase in violence | 2.11 (0.98, 4.55) | – | 2.11 (0.98, 4.55) | – |
 Increase in difficulty accessing health/social services | 4.72 (2.72, 8.18) | 2.66 (1.41, 5.02) | 4.72 (2.72, 8.18) | – |
 Inability to self-isolate or social distance | 2.53 (1.46, 4.39) | 2.13 (1.10, 4.14) | 2.53 (1.46, 4.39) | 2.21 (1.24, 3.94) |